Human milk oligosaccharides inhibit growth of group B Streptococcus.
Ontology highlight
ABSTRACT: Streptococcus agalactiae (group B Streptococcus, GBS) is a leading cause of invasive bacterial infections in newborns, typically acquired vertically during childbirth secondary to maternal vaginal colonization. Human milk oligosaccharides (HMOs) have important nutritional and biological activities that guide the development of the immune system of the infant and shape the composition of normal gut microbiota. In this manner, HMOs help protect against pathogen colonization and reduce the risk of infection. In the course of our studies of HMO-microbial interactions, we unexpectedly uncovered a novel HMO property to directly inhibit the growth of GBS independent of host immunity. By separating different HMO fractions through multidimensional chromatography, we found the bacterio
SUBMITTER: Lin AE
PROVIDER: S-EPMC5500792 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
ACCESS DATA